All Cytology Legislation - Federal Government
S.2863 - A bill to amend the Internal Revenue Code of 1986 to provide a Federal income tax credit for certain stem cell research expenditures.
Latest Action: 04/15/2008 - Read twice and referred to the Committee on Finance. Bill Text A bill to amend the Internal Revenue Code of 1986 to provide a Federal income tax credit for certain stem cell research expenditures. 4/15/2008--Introduced.
Ethical Stem Cell Research Tax Credit Act of 2008 - Amends the Internal Revenue Code to allow a tax credit for 30% of qualified stem cell research expenses paid or incurred in a taxable year. Defines "qualified stem cell research expenses" as expenses for carrying out basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of or treatments for diseases and other adverse health conditions. Prohibits a tax credit for any research expenses that may involve: (1) the creation of a human embryo for research purposes; (2) the destruction of or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell for prohibited purposes. Comment on Bill S.2510 - A bill to amend the Public Health Service Act to provide revised standards for quality assurance in screening and evaluation of gynecologic cytology preparations, and for other purposes.
Latest Action: 12/18/2007 - Sponsor introductory remarks on measure. (CR S15920) Bill Text A bill to amend the Public Health Service Act to provide revised standards for quality assurance in screening and evaluation of gynecologic cytology preparations, and for other purposes. 12/18/2007--Introduced. Cytology Proficiency Improvement Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to revise national quality assurance standards to assure consistent performance by laboratories of valid and reliable cytology services, to include requirements that each clinical laboratory: (1) ensure that all individuals involved in screening and interpreting cytological preparations participate annually in an approved continuing medical education program in gynecologic cytology that provides each participant with gynecologic cytological preparations designed to improve locator, recognition, and interpretive skills; (2) maintain a record of program results; (3) require the laboratory director to consider such results and other [...] show full description H.R.3043 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2008, and for other purposes.
Latest Action: 11/15/2007 - DEBATE - The House proceeded with one hour of debate on the question of passage, the objections of the President to the contrary notwithstanding. Bill Text Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2008, and for other purposes. 11/7/2007--Senate receded and concurred with amendment. (There are 4 other summaries) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008 - Makes appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for FY2008. Title I: Department of Labor - Department of Labor Appropriations Act, 2008 - Makes appropriations for FY2008 to the Department of Labor for: (1) the Employment and Training Administration, including training and employment services; (2) community service employment for older Americans; (3) federal unemployment benefits and allowances; (4) state unemployment insurance and employment service operations; (5) advances to the Unemployment [...] show full description H.R.2807 - To intensify stem cell research showing evidence of substantial clinical benefit to patients, and for other purposes.
Latest Action: 06/21/2007 - Referred to the Subcommittee on Health. Bill Text To intensify stem cell research showing evidence of substantial clinical benefit to patients, and for other purposes. 6/21/2007--Introduced. Patients First Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not such pluripotent stem cells have an embryonic source), provided that such techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this Act.Requires [...] show full description H.R.2731 - To improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes.
Latest Action: 06/14/2007 - Referred to the Subcommittee on Health. Bill Text To improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes. 6/14/2007--Introduced. Safe Tissue Act - Requires the Food and Drug Administration (FDA) to inspect, at least once every two years, each establishment that engages in the manufacture of human cells, tissues, and cellular and tissue-based products. Allows the Secretary of Health and Human Services to establish a user fee to fund such inspections. Requires the FDA to conduct periodic audits of all documentation submitted by each such establishment to determine compliance with all applicable requirements, including requirements related to ensuring: (1) that human cells, tissues, or cellular or tissue-based products are obtained legally; (2) that donor eligibility and donor medical history interviews are based on accurate information that was not provided or obtained in a fraudulent manner; and (3) current good tissue practice. Requires the Secretary [...] show full description S.1479 - A bill to improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes.
Latest Action: 05/24/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill Text A bill to improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes. 5/24/2007--Introduced. Safe Tissue Act - Requires the Food and Drug Administration (FDA) to inspect, at least once every two years, each establishment that engages in the manufacture of human cells, tissues, and cellular and tissue-based products. Allows the Secretary of Health and Human Services to establish a user fee to fund such inspections. Requires the FDA to conduct periodic audits of all documentation submitted by each such establishment to determine compliance with all applicable requirements, including requirements related to ensuring: (1) that human cells, tissues, or cellular or tissue-based products are obtained legally; (2) that donor eligibility and donor medical history interviews are based on accurate information that was not provided or obtained in a fraudulent manner; and (3) current good tissue practice. Requires the Secretary [...] show full description H.R.1892 - To direct the Secretary of Health and Human Services to provide for the establishment and maintenance of a National Amniotic and Placental Stem Cell Bank.
Latest Action: 04/18/2007 - Referred to the Subcommittee on Health. Bill Text To direct the Secretary of Health and Human Services to provide for the establishment and maintenance of a National Amniotic and Placental Stem Cell Bank. 4/17/2007--Introduced.
National Amniotic and Placental Stem Cell Bank Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to establish and maintain the National Amniotic and Placental Stem Cell Bank to obtain, store, and make available for research and treatment human stem cells derived from amniotic fluid or placenta. Requires the Bank to maintain not fewer than 100,000 samples of human stem cells. Allows the Bank to obtain a stem cell only if the woman providing the amniotic fluid or placenta makes a written statement of informed consent. S.30 - A bill to intensify research to derive human pluripotent stem cell lines.
Latest Action: 04/16/2007 - Received in the House. Bill Text A bill to intensify research to derive human pluripotent stem cell lines. 4/11/2007--Passed Senate without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Hope Offered through Principled and Ethical Stem Cell Research Act or the HOPE Act - (Sec. 3) Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source), that may result in improved understanding of or treatments for diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a human embryo or embryos for research purposes; or (2) the destruction or discarding of, or [...] show full description S.997 - A bill to amend the Public Health Service Act to provide for human embryonic stem cell research.
Latest Action: 03/28/2007 - Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 94. Bill Text A bill to amend the Public Health Service Act to provide for human embryonic stem cell research. 3/27/2007--Introduced. Stem Cell Research Enhancement Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following ethical requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics for the purpose of fertility treatment and were in excess of the needs of the individuals seeking such treatment; (2) the embryos would never be implanted in a woman and would otherwise be discarded; and (3) such individuals donate the embryos with written informed consent and receive no financial or other inducements. Requires the Secretary to develop techniques for the isolation, derivation,[...] show full description S.957 - A bill to provide for the collection and maintenance of amniotic fluid and placental stem cells for the treatment of patients and research.
Latest Action: 03/22/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill Text A bill to provide for the collection and maintenance of amniotic fluid and placental stem cells for the treatment of patients and research. 3/22/2007--Introduced.
Amniotic Fluid and Placental Stem Cell Banking Act of 2007 - Directs the Secretary of Health and Human Services to enter into one-time contracts with qualified amniotic fluid and placental stem cell banks to assist in the collection and maintenance of 100,000 new units of high-quality amniotic fluid and placental stem cells to be made available for treatment though the C.W. Bill Young Cell Transplantation and Treatment Program. Sets forth provisions relating to requirements for contract recipients, the duration of such contracts, and extensions of funding under such contracts. Amends the Public Health Service Act to revise the Program to provide for amniotic fluid and placental stem cell functions, recruitment, and educational activities. Authorizes appropriations for the Program through FY2012. S.812 - A bill to prohibit human cloning and protect stem cell research.
Latest Action: 03/08/2007 - Sponsor introductory remarks on measure. (CR S2905) Bill Text A bill to prohibit human cloning and protect stem cell research. 3/8/2007--Introduced. Human Cloning Ban and Stem Cell Research Protection Act of 2007 - Prohibits: (1) conducting or attempting to conduct human cloning; (2) shipping the product of nuclear transplantation in interstate or foreign commerce for the purpose of human cloning in the United States or elsewhere; or (3) exporting to a foreign country an unfertilized blastocyst if such country does not prohibit human cloning. Sets forth criminal and civil penalties for violations. Requires the Comptroller General to report to the relevant congressional committees on: (1) actions taken to enforce such prohibitions; (2) actions of state attorneys general to enforce similar state laws; (3) coordination of federal, state, and local enforcement; and (4) international laws relating to human cloning. Amends the Public Health Service Act to require research involving nuclear transplantation to be conducted in accordance [...] show full description H.R.1237 - To amend the Public Health Service Act to provide revised standards for quality assurance in screening and evaluation of gynecologic cytology preparations, and for other purposes.
Latest Action: 04/09/2008 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill Text To amend the Public Health Service Act to provide revised standards for quality assurance in screening and evaluation of gynecologic cytology preparations, and for other purposes. 4/8/2008--Passed House amended. (There is 1 other summary) Cytology Proficiency Improvement Act of 2008 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to revise national quality assurance standards to assure consistent performance by laboratories of valid and reliable cytology services in order to include requirements that each clinical laboratory: (1) ensure that all individuals involved in screening and interpreting cytological preparations participate annually in an approved continuing medical education program in gynecologic cytology that provides each participant with gynecologic cytological preparations designed to improve locator, recognition, and interpretive skills; (2) maintain a record of program results; (3) require [...] show full description S.362 - A bill to expand the number of embryonic stem cell lines available for federally funded research.
Latest Action: 01/23/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill Text A bill to expand the number of embryonic stem cell lines available for federally funded research. 1/23/2007--Introduced.
Stem Cell Research Expansion Act - Authorizes the Department of Health and Human Services to provide funding for research on embryonic stem cell lines that were created prior to January 23, 2006, that does not result in the use of federal funding to destroy an embryo. S.363 - A bill to provide increased Federal funding for stem cell research, to expand the number of embryonic stem cell lines available for Federally funded research, to provide ethical guidelines for stem cell research, to derive human pluripotent stem cell lines using techniques that do not create an embryo or embryos for research or knowingly harm human embryo or embryos, and for other purposes.
Latest Action: 01/23/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill Text A bill to provide increased Federal funding for stem cell research, to expand the number of embryonic stem cell lines available for Federally funded research, to provide ethical guidelines for stem cell research, to derive human pluripotent stem cell lines using techniques that do not create an embryo or embryos for research or knowingly harm human embryo or embryos, and for other purposes. 1/23/2007--Introduced. Hope Offered through Principled, Ethically-Sound Stem Cell Research Act or the HOPE Act - Requires the Secretary of Health and Human Services to conduct and support research to develop techniques for the isolation, derivation, production, or testing of pluripotent stem cells that have the flexibility of embryonic stem cells and that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a viable human embryo for research purposes; (2) the destruction [...] show full description H.R.457 - To amend the Internal Revenue Code of 1986 to provide credits against income tax for qualified stem cell research, the storage of qualified stem cells, and the donation of umbilical cord blood.
Latest Action: 01/12/2007 - Sponsor introductory remarks on measure. (CR E93) Bill Text To amend the Internal Revenue Code of 1986 to provide credits against income tax for qualified stem cell research, the storage of qualified stem cells, and the donation of umbilical cord blood. 1/12/2007--Introduced.
Cures Can Be Found Act of 2007 - Amends the Internal Revenue Code to allow tax credits for donations: (1) to stem cell research or storage facilities; (2) of umbilical cord blood. Allows credits only for donations to facilities that do not engage in research on stem cells derived from human embryos. Allows a business tax credit for stem cell research and storage expenses. H.R.322 - To derive human pluripotent stem cell lines using techniques that do not harm human embryos.
Latest Action: 06/25/2007 - Sponsor introductory remarks on measure. (CR H7063-7065) Bill Text To derive human pluripotent stem cell lines using techniques that do not harm human embryos. 1/9/2007--Introduced.
Alternative Pluripotent Stem Cell Therapies Enhancement Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but are not derived from a human embryo. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research. H.R.3 - To amend the Public Health Service Act to provide for human embryonic stem cell research.
Latest Action: 01/12/2007 - Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 6. Bill Text To amend the Public Health Service Act to provide for human embryonic stem cell research. 1/11/2007--Passed House without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Stem Cell Research Enhancement Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo, provided such embryos: (1) have been donated from in vitro fertilization clinics; (2) were created for the purposes of fertility treatment; (3) were in excess of the needs of the individuals seeking such treatment and would never be implanted in a woman and would otherwise be discarded (as determined in consultation with the individuals seeking fertility treatment);[...] show full description H.RES.6 - Adopting the Rules of the House of Representatives for the One Hundred Tenth Congress.
Latest Action: 01/05/2007 - Considered as unfinished business. Bill Text Adopting the Rules of the House of Representatives for the One Hundred Tenth Congress. 1/5/2007--Passed House without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Title I: Adoption of Rules of One Hundred Ninth Congress - (Sec. 101) Adopts the Rules of the House of Representatives for the 109th Congress as the Rules for the 110th Congress, with amendments. Title II: Ethics - (Sec. 202) Amends Rule XXIII (Code of Official Conduct) to prohibit Members, with the intent to influence on the basis of partisan political affiliation an employment decision or practice of private entities, from: (1) taking or withholding, or offering or threatening to to take or withhold, an official act; or (2) influencing, or offering or threatening to influence, the official act of another. (Sec. 203) Amends Rule [...] show full description S.5 - A bill to amend the Public Health Service Act to provide for human embryonic stem cell research.
Latest Action: 06/20/2007 - Veto message received in Senate. Ordered held at the desk. Bill Text A bill to amend the Public Health Service Act to provide for human embryonic stem cell research. 6/7/2007--Passed House without amendment. (There are 2 other summaries) (This measure has not been amended since it was introduced. The expanded summary of the Senate passed version is repeated here.) Stem Cell Research Enhancement Act of 2007 - (Sec. 2) Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following ethical requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics for the purpose of fertility treatment and were in excess of the needs of the individuals seeking such treatment; (2) the embryos would never be implanted in a woman and would [...] show full description S.51 - A bill to derive human pluripotent stem cell lines using techniques that do not knowingly harm embryos.
Latest Action: 01/04/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill Text A bill to derive human pluripotent stem cell lines using techniques that do not knowingly harm embryos. 1/4/2007--Introduced. Pluripotent Stem Cell Therapy Enhancement Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source) and that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a viable human embryo for research purposes; or (2) the destruction or discarding of a human embryo or embryos; or (3) knowingly subjecting a human embryo or embryos to risk of injury or death greater than that allowed for federal research on fetuses in utero under current law. Requires the Secretary to: (1) provide guidance [...] show full description |
 Bill Categories in Federal Government
|
